Patient Access

Who has access?

Patients in South Australia can access medicinal cannabis medicines as a result of federal legislative changes which came into effect in November 2016 and the development of a patient access pathway.

Under the pathway, patients in South Australia can access medicinal cannabis on prescription from their authorised medical practitioner and dispensed by a pharmacist. The decision to consider medicinal cannabis as a treatment option is a matter for discussion between a medical practitioner and their patient, enabling consideration of the patient’s clinical information and the safety and efficacy of medicinal cannabis in the particular condition to be treated.

Importantly, medical practitioners must notify or apply for approval to the Commonwealth TGA to prescribe an unregistered medicinal cannabis product. Note, there is not a restricted list of medical conditions for which medicinal cannabis may be prescribed in South Australia.

Consistent with the requirements for Schedule 4 medicines in South Australia, there is no requirement for a medical practitioner to obtain State approval to prescribe a Schedule 4 cannabidiol (CBD) medicine.

The Drug Wheel

According to the Alcohol and Drug Foundation, the Drug Wheel classifies drugs as part of seven general categories: Stimulants, Depressants, Cannabinoids, Psychedelics, Opioids, Dissociatives and Empathogens. Find out about the effects of drugs and more information about specific drugs.

Click image to enlarge (opens in new window)

The ADF interactive Drug Wheel is based on the Drugs Wheel by Mark Adley and is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Unported License. Permissions beyond the scope of this license may be available by contacting webmanagement@adf.org.au

168+

People

6 leading

Universities

12

Countries

15

Collaborations